Kimberly-Clark está comprando al fabricante de Tylenol, Kenvue, en un acuerdo de efectivo y acciones valorado en ...
Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.
Kimberly-Clark’s third-quarter profit fell 51% as a result of divestitures, business exits and recent tariffs, although sales ...
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...